Meridian Clinical Research
Macon, Georgia, United States
Medical clinic in Bibb County, Georgia
5300 Bowman Rd, Macon, GA 31210
About Meridian Clinical Research
"Meridian's Macon, GA, location performs clinical studies related to conditions that affect children and adolescents under the age of 21."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Meridian Clinical Research
During the past decade, Meridian Clinical Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
2001-03-01
2008-11-01
Completed
S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
2006-04-01
Unknown status
500
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
2005-07-01
2021-12-13
Completed
6,927
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
2013-07-01
2014-06-01
Terminated
18
Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
2014-01-01
2019-12-01
Completed
310
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Meridian Clinical Research
According to Clinical.Site data, the most researched conditions in "Meridian Clinical Research" are
"Gastrointestinal Tolerance" (1 trials), "Pediatric Migraine" (1 trials), "Pneumococcal Disease" (1 trials), "Respiratory Infections in Children" (1 trials) and "SARS-CoV-2" (1 trials). Many other conditions were trialed in "Meridian Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Meridian Clinical Research
Most popular intervention types in "Meridian Clinical Research" are "Biological" (2 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Control Infant Formula" (1 trials), "Control Toddler Drink" (1 trials) and "Experimental Infant Formula" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Meridian Clinical Research
The vast majority of trials in "Meridian Clinical Research" are
5 trials for "All" genders.
Clinical Trials Status at Meridian Clinical Research
Currently, there are NaN active trials in "Meridian Clinical Research".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Meridian Clinical Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Meridian Clinical Research, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".